This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery

This study has been withdrawn prior to enrollment.
Information provided by (Responsible Party):
Revalesio Corporation Identifier:
First received: August 9, 2013
Last updated: April 8, 2015
Last verified: January 2015
The purpose of this study is to see if use of RNS60 during ACL reconstruction surgery decreases pain and improves functional capacity post-operation.

Condition Intervention Phase
Anterior Cruciate Ligament Reconstruction Drug: RNS60 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Knee Anterior Cruciate Reconstruction Surgery

Resource links provided by NLM:

Further study details as provided by Revalesio Corporation:

Primary Outcome Measures:
  • Assessment of Post-operative pain [ Time Frame: 1 week ]
    Comparison of scores from validated pain scales from post-surgery to one week

Enrollment: 0
Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   Child, Adult, Senior
Accepts Healthy Volunteers:   No
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Revalesio Corporation Identifier: NCT01922427     History of Changes
Other Study ID Numbers: 07.1.1.H1
Study First Received: August 9, 2013
Last Updated: April 8, 2015 processed this record on August 18, 2017